The global clarithromycin market is anticipated to gain growth at a significant CAGR during the forecast period. Clarithromycin is a macrolide antibiotic produced from erythromycin that is utilised to treat bacterial infections such as pneumonia, bronchitis, ear infections, sinus infections, skin infections, and throat infections. Clarithromycin is also used to treat tonsillitis and pharyngitis, and Helicobacter pylori infection.

Clarithromycin is a drug that can be used by people of all ages, including children and adults, and hence has a wide global market. Clarithromycin is a generic antibiotic that is used to treat bacteria that cause skin and respiratory infections, that help to expand the global Clarithromycin market. Clarithromycin is more widely used by people who are allergic to penicillin. However, clarithromycin is ineffective during a cold, flu, or other viral infection. Patients who are allergic to chemically related macrolide antibiotics or specific antibiotics, such as erythromycin, should avoid taking clarithromycin. 

Clarithromycin is mainly used to treat ulcers caused by H. pylori, which affect a large percentage of the world's population. According to the CDC, H. pylori causes more than 90% of ulcers, and between 600,000 and 850,000 new cases of ulcer disease are registered every year, affecting people of all ages. As there is no vaccine is available, the global market for clarithromycin is anticipated to grow. Despite several disadvantages, such as side effects, restrictions on use by people with specific conditions, and allergies to erythromycin, the global market for clarithromycin is growing.

Although the majority of the products are introduced in the generic antibiotic market,  there is tough competition among local and regional players, and due to the high prevalence of ulcers caused by H. pyroli a huge demand for clarithromycin is anticipated in near future. 

Market Coverage

    • The market number available for – 2021-2027

    • The base year – 2020 

    • The forecast period is from 2021 to 2027

    • Segment Covered- 

o By Product Type 

o By Application

o By End-User

    • Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape: Abbvie, Abbott, West-Ward Pharms, Actavis Labs Fl Inc., Sun Pharm Inds, Mylan, Mayne Pharma, Apotex Pharmaceutical Holdings Inc., Takeda Pharmaceutical Ltd. 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Clarithromycin Market by Segments 

By Product type 

    • Tablet

    • Capsule

    • Suspension

By Application

    • Dermatology

    • ENT

    • Pediatric

    • Thoracic & Cardiovascular

    • Pulmonary Medicine

By End-User 

    • Hospital Pharmacy

    • Retail Pharmacy

    • Clinics

    • Ecommerce

    • Others 

Global Claritheomycin Market by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • Rest of Asia-Pacific

Rest of the World

    • Latin America 

    • Middle East & Africa